联系我们

论文查询结果	返回搜索

论文编号：	15519
作者编号：	2320224217
上传时间：	2025/6/16 7:28:40
中文题目：	H医药公司销售与收款环节内部控制优化研究
英文题目：	Research on Internal Control of Sales and Collection Process of H Pharmaceutical Company
指导老师：	李姝教授
中文关键字：	销售与收款环节；医药公司；内部控制
英文关键字：	Sales and Collection Process; Pharmaceutical Company; Internal Control
中文摘要：	医药企业作为我国国民经济中的一个较为特殊的经济运行主体，不仅是医药产品的生产方和销售方，更是当下社会健康稳定发展责任的重要承担者。近年来医药企业不断成长壮大，推动了整个医药行业的持续发展，但与此同时，医药企业财务造假、医药贿赂等恶性事件也层出不穷，严重威胁着医药企业的持续稳定发展，在这种情况下加强内部控制极为重要，以便为医药企业实现健康持续性发展护航。然而结合相应数据统计发现，当前我国医药企业未建立完善的内部控制体系并非个案，其自身现存的内部控制制度难以有效运行。销售与收款环节作为企业各项业务之中最为重要的一环，其产生的风险更应当作为企业运营和管理过程中的重点关注对象。医药企业只有加强对销售与收款环节内部控制的重视，才能有效地进行风险防范，进而持续推进我国整个医药行业平稳健康地发展。 H医药公司是一家主要经营药品研发和制造的公司。本文以H医药公司销售与收款环节的内部控制体系作为研究对象，首先对企业内部控制的相关理论进行汇总整理，在此基础上对H医药公司以及其销售与收款环节的内部控制现状及存在的问题进行了阐述。随后，本文着重分析了H医药公司销售与收款环节内部控制中存在的问题，包括关键控制活动的设计存在漏洞、风险评估机制不够健全、信息与沟通机制不完善以及缺乏有效的内部监督共四大类问题，并对H医药公司相关问题的负面影响及造成问题的原因进行阐述。最后，本文以COSO内部控制框架作为理论基础，结合《企业内部控制基本规范》、《企业内部控制应用指引》等规范文件的指引，对上述问题有针对性地提出相应的优化建议。 通过本文研究，期望能进一步完善和优化H医药公司内部控制体系，提升H医药公司销售与收款环节的风险应对能力，进而推动H医药公司稳步发展，增强H医药公司在当下较为复杂且高速发展的市场环境下的竞争力。同时，开展本文研究还希望能为同行其他企业完善其内部控制体系提供参考，提升其市场竞争力。
英文摘要：	As a relatively special economic entity in China's national economy, pharmaceutical companies are not only the producers of and sellers of pharmaceutical products, but also important bearers of responsibility for the healthy and stable development of society. In recent years, pharmaceutical companies have continued to grow and expand, promoting the sustainable development of the entire pharmaceutical industry. However, at the same time, malicious incidents such as financial fraud and pharmaceutical bribery in pharmaceutical companies have emerged in an endless stream, threatening the sustainable and stable development of pharmaceutical companies. In this case, internal control, as an important means of enterprise risk prevention and management, affects the operation and development of the enterprise itself. However, at present, many pharmaceutical companies in China have not yet established relatively perfect internal control systems, and their existing internal control systems are difficult to operate effectively. As the most important part of a company's various businesses, the risks arising from sales and collection should be the focus of attention in the process of enterprise operation and management. Only by strengthening the attention to internal control of sales and collection links can pharmaceutical companies effectively prevent risks and promote the stable and healthy development of the entire pharmaceutical industry in China. H Pharmaceutical Company is a company mainly engaged in drug research and manufacturing. This paper takes the internal control system of H Pharmaceutical Company's sales and payment processes as the research object. Firstly, the relevant theories of internal control in the enterprise are summarized and organized. Based on this, the current situation and existing problems of internal control in H Pharmaceutical Company and its sales and payment processes are elaborated. Subsequently, this paper focuses on analyzing four major issues: loopholes in the design of key control activities, inadequate risk assessment mechanisms, incomplete internal and external information and communication mechanisms, and lack of effective internal supervision. It also elaborates on the negative impact of H Pharmaceutical Company's related issues and the reasons for the problems. Finally, this paper takes the COSO internal control framework as the theoretical basis, and combines the guidance of normative documents such as the Basic norms of internal control and the Guidelines for the application of enterprise internal control to propose targeted optimization suggestions for the above-mentioned issues. Through this study, it is expected to further improve and optimize the internal control system of H Pharmaceutical Company, enhance its risk response capabilities in sales and payment processes, and promote the steady development of H Pharmaceutical Company, thereby enhancing its competitiveness in the current complex and rapidly developing market environment. At the same time, it is hoped that the research content of this paper can provide some reference for companies in the same industry to optimize their internal controls in the sales and collection processes.
查看全文：	预览  下载(下载需要进行登录)